SEC Form 4/A · accession 0001513162-17-000260
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John J Monahan
Director
Period of report
Jan 3, 2017
Accepted (ET)
Sep 11, 2017 · 9:12 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F1,F3,F2 | $5.30 | Jan 3, 2017 | A | 12,000 | A | — | Jan 3, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
- F2options vest and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017.
- F3This Form 4/A is being filed to correct a typo in the expiration date column to reflect that the Employee Stock Option expires on January 3, 2027, not January 3, 2017.